We inform you that your data will be processed for the sole purpose of providing information on the services requested.


Diasorin Diasorin Diasorin Diasorin Diasorin Diasorin Diasorin Diasorin

About the project

DiaSorin is a leader in immunodiagnostics and molecular diagnostics, for which it develops, manufactures and markets analysis kits, tools and software. Immunoreactive kits are mainly based on three different technologies: ChemiLuminescent Immuno Assay (CLIA), Enzyme Linked ImmunoSorbent Assay (ELIA), Radio Immuno Assay (RIA). In the field of Molecalar Diagnostics, for which amplification and expansion techniques are followed, DiaSorin developed a new technology for the first phase of DNA amplification (Q-LAMP), while the second phase benefited from the Norwegian NorDiag company's know-how, leader in the RNA-DNA extraction sector, which joined the Group following an acquisition.Leader in the field of in vitro diagnostics and in immunodiagnostic tests for bone health, DiaSorin is one of the world leaders in technological innovation in the sector. Research and Development investments allow the Group to launch every year on the international market the highest number of diagnostic tests, always maintaining a high-quality standard. At the 2013 edition of Eurolab (IFCC-EFCC European Congress of Clinical Chemistry and Laboratory Medicine) held at the Milan Congress Centre, Honegger ideates and realises the exhibition space of DiaSorin SpA. Eurolab combines exhibition activities of companies with congress activities.